UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016169
Receipt number R000018769
Scientific Title A phase I/II clinical trial of prophylactic extended-field radiotherapy of pelvic and para-aortic lymph nodes in locally advanced squamous cell carcinoma of the uterine cervix using carbon-ion beams
Date of disclosure of the study information 2015/01/09
Last modified on 2015/01/09 13:44:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase I/II clinical trial of prophylactic extended-field radiotherapy of pelvic and para-aortic lymph nodes in locally advanced squamous cell carcinoma of the uterine cervix using carbon-ion beams

Acronym

Cervix IV

Scientific Title

A phase I/II clinical trial of prophylactic extended-field radiotherapy of pelvic and para-aortic lymph nodes in locally advanced squamous cell carcinoma of the uterine cervix using carbon-ion beams

Scientific Title:Acronym

Cervix IV

Region

Japan


Condition

Condition

uterine cervical cancer

Classification by specialty

Obstetrics and Gynecology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and toxicity of prophylactic extended-field C-ion RT for locally advanced squamous cell carcinoma of the uterine cervix.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Acute toxicity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Other

Interventions/Control_1

Prophylactic extended-field (Pelvic and para-aorta lymph node regions) Carbon-ion radiotherapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

80 years-old >=

Gender

Female

Key inclusion criteria

1. Pathologically proven squamous cell carcinoma of the uterine cervix
2. International Federation of Gynecology and Obstetrics (FIGO 1994) Stage IIB with tumor size > 4 cm in diameter, III, or IVA disease without rectal invasion
3. Patient does not have para-aortic lymph nodes > 1 cm in minimum diameter on CT image
4. Tumor must be grossly measurable
5. Age < 80 years
6. World Health Organization performance status < 3
7. Adequate bone marrow function; WBC > 3000 cells/mm3, Platelets > 100,000 cells/mm3, Hemoglobin > 10.0 g/dl
8. Estimated life expectancy > 6 months
9. Patient provides written informed consent to participate in this study before initiation of therapy.

Key exclusion criteria

1. Severe co-morbidity; severe pelvic infection, severe psychological illness etc.
2. Active synchronous cancer
3. Prior radiotherapy to the pelvic or para-aortic region
4. Prior chemotherapy
5. Medical, psychological or other factor deciding ineligibility by attending physician

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michiya Suzuki

Organization

National Institute of Radiological Sciences

Division name

Research Center Hospital for Charged Particle Therapy

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, 263-8555 JAPAN

TEL

043-206-3306

Email

waka@nirs.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masaru Wakatsuki

Organization

National Institute of Radiological Sciences

Division name

Research Center Hospital for Charged Particle Therapy

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, 263-8555 JAPAN

TEL

043-206-3306

Homepage URL


Email

wakkun100@yahoo.co.jp


Sponsor or person

Institute

National Institute of Radiological Sciences

Institute

Department

Personal name



Funding Source

Organization

National Institute of Radiological Sciences

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

放射線医学総合研究所(千葉県)


Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 02 Month 15 Day

Date of IRB


Anticipated trial start date

2006 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 09 Day

Last modified on

2015 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018769


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name